新生儿低血压的药理学管理的最新情况:何时,为什么,以及哪些药物
Eleni Agakidou1, Ilias Chatziioannidis1, Angeliki Kontou1
11st Department of Neonatology and Neonatal Intensive Care, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Ippokrateion General Hospital, 54642 Thessaloniki, Greece.
Children (Basel, Switzerland)
|April 27, 2024
概括
新生儿动脉低血压 (AH) 治疗需要澄清. 本综述考察了抗潜在药物,它们在新生儿中的使用,以及改善临床实践和长期结果的知识差距.
科学领域:
- 新生儿医学 新生儿医学
- 儿科药理学 儿科药理学
- 关键的护理关键的护理
背景情况:
- 新生儿的动脉低血压 (AH) 用各种药物治疗,但仍然存在重大知识差距.
- 挑战包括定义正常血压范围,确定关键 perfusion 值,以及优化药物治疗策略.
- 有限的随机试验和稀少的长期神经发育数据使基于证据的实践复杂化.
研究的目的:
- 审查新生儿动脉低血压的当前抗低血压治疗方法.
- 讨论这些药物的药理动力学,血液动力学,疗效和安全性数据.
- 根据现有证据,提供关于药物选择和适应症的指导.
主要方法:
- 对新生儿使用的抗潜在药物的文献综述.
- 对病理生理学,药理动力学,血液动力学,疗效和安全性的数据进行分析.
- 对比疗效和临床适应症的讨论.
主要成果:
- 已确定的抗潜在性药物包括多巴胺,多布胺,上腺素,上腺素,米利诺,压缩素,特利普林素,levosimendan和葡萄糖皮质类药物.
- 目前关于药物效应,最佳使用和长期影响的数据仍然有限.
- 基于证据的比较和单个药物的明确指示仍在发展.
结论:
- 需要进一步的研究,包括强大的临床试验,以解决新生儿AH管理当前的知识差距.
- 优化抗低压疗法需要更好地了解血压目标和药物对器官输液的影响.
- 改进的证据对于改善AH新生儿的短期结果和长期神经发育轨迹至关重要.
相关概念视频
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
442
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
442
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:23Antihypertensive Drugs: Vasodilators
513
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
513
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
783
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
783
01:30Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422